On-demand video webcast now available here PRINCETON, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the ...
Free Claude users will get the standard, non-reasoning version of Claude 3.7 Sonnet, which Anthropic claims outperforms its previous frontier AI model, Claude 3.5 Sonnet. (Yes, the company skipped ...
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...
Anthropic has unveiled Claude 3.7 Sonnet, a notable addition to its lineup of large language models (LLMs), building on the foundation of Claude 3.5 Sonnet. Marketed as the first hybrid reasoning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results